Cloudnine to acquire Apollo’s maternity chain Cradle
Cloudnine has signed an exclusivity agreement to acquire Apollo Cradle and the proposed transaction is expected to value the business at around ₹1,500 crore. Earlier in June last year, ET…
Cloudnine has signed an exclusivity agreement to acquire Apollo Cradle and the proposed transaction is expected to value the business at around ₹1,500 crore. Earlier in June last year, ET…
First regimen to be approved in India to demonstrate superiority to platinum-containing chemotherapy, the current standard of care for adult patients with unresectable or metastatic urothelial cancer for nearly 40…
The program brought together cancer survivors, caregivers, oncologists, and healthcare professionals to celebrate stories of hope and perseverance while highlighting the emotional and psychological aspects of cancer recovery.
For the full financial year FY26, consolidated revenue grew 16 per cent YoY to Rs 25,229 crore with a net profit of Rs 1,942 crore.
The study also identified notable sleep-related differences, with men reporting higher rates of REM-sleep behaviour disorder and sleep apnoea, compared to women. REM or rapid eye movement sleep, is the…
The insurer said the new product would retain features available in mainstream plans while being priced lower for non-metro markets. Metro cities have been excluded from the offering as healthcare…
Emphasising India's efforts towards pandemic preparedness, Nadda stated that the Government is continuously strengthening healthcare infrastructure and emergency response capacities to effectively address future public health challenges.
The investigation by Radio France, RTBF and RTS said Nestle had delayed alerting European authorities about the presence of cereulide, a toxin that can cause vomiting and diarrhoea and poses…
The PIL relies upon various media reports, medical journals, and research papers to highlight alleged health concerns linked to unsafe tattooing practices. It refers to reports concerning alleged HIV transmission…
The decision comes after action against several centres for alleged violations of the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act.